コンテンツへスキップ
Merck

[The calcipotriol-betamethasone dipropionate association].

Revue medicale de Liege (2006-01-13)
F Henry, C Flagothier, P Delvoye, C Piérard-Franchimont, G E Piérard
要旨

The topical treatment of psoriasis benefits from the alternate use of dermocorticosteroids and vitamin D3 analogues. A new galenic formulation allows to combine them in a single application. Dovobet (LEO Pharma) ointment is the association of calcipotriol 50 microg/g with betamethasone dipoprionate 0.5 mg/g. This formulation boosts the therapeutic activity of calcipotriol. It also decreases the irritative inflammatory reaction due to calcipotriol without increasing the atrophogenic risk of the dermocorticoid.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ベタメタゾン, ≥98%
USP
Betamethasone dipropionate, United States Pharmacopeia (USP) Reference Standard
Supelco
Betamethasone Dipropionate, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
ベタメタゾン, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Betamethasone 17,21-dipropionate
Supelco
ベタメタゾン, VETRANAL®, analytical standard
Betamethasone dipropionate, European Pharmacopoeia (EP) Reference Standard
ベタメタゾン, European Pharmacopoeia (EP) Reference Standard
Betamethasone dipropionate for peak identification, European Pharmacopoeia (EP) Reference Standard